108:
is an HIV researcher focused on improving outcomes for people living with HIV/AIDS through the understanding of barriers to accessing HIV testing, treatment and care in Canada and globally. He is a senior research scientist and the former
Director of the HIV/AIDS Drug Treatment Program at the B.C.
157:
and others are original authors of the
Treatment as prevention strategy (TasP). The Treatment as Prevention strategy is based on the premise that administering highly active antiretroviral therapy to all medically eligible HIV-positive individuals will decrease transmission rates.
113:
Distinguished
Professor (the first to receive the title) and the Associate Dean of Research of the faculty of Health Sciences. He is a prolific and highly cited author with an H-index of 111 and over 1000 peer-reviewed papers. He is both a Member of the
508:
Montaner, JS; Hogg, R; Wood, E; Kerr, T; Tyndall, M; Levy, AR; Harrigan, PR (Aug 5, 2006). "The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic".
357:
Strathdee, SA; Palepu, A; Cornelisse, PG; Yip, B; O'Shaughnessy, MV; Montaner, JS; Schechter, MT; Hogg, RS (12 August 1998). "Barriers to use of free antiretroviral therapy in injection drug users".
129:
Dr. Hogg's research has extensively covered access and barriers to care such as his 1998 senior author paper looking at barriers to the use of free antiretroviral therapy in injection drug users.
443:
Hogg, Robert S.; Bangsberg, David R.; Lima, Viviane D.; Alexander, Chris; Bonner, Simon; Yip, Benita; Wood, Evan; Dong, Winnie W. Y.; Montaner, Julio S. G.; Harrigan, P. Richard (2006).
121:
His research includes, access to care including at risk-groups including those that use drugs or men that have sex with men, antiretroviral therapy, and aging with HIV.
568:
400:
Hogg, RS; O'Shaughnessy, MV; Gataric, N; Yip, B; Craib, K; Schechter, MT; Montaner, JS (3 May 1997). "Decline in deaths from AIDS due to new antiretrovirals".
137:
Hogg has published extensively on antiretroviral therapy from their inception to current times such as looking at antiretrovirals' effect on mortality.
563:
145:
Hogg's 2006 paper demonstrated that resistance to NNRTIs resulted in greater mortality than the development of resistance to protease inhibitors.
219:
573:
309:
255:
445:"Emergence of Drug Resistance Is Associated with an Increased Risk of Death among Patients First Starting HAART"
110:
558:
273:
534:
425:
382:
167:
526:
476:
417:
374:
172:
518:
466:
456:
409:
366:
237:
115:
104:
291:
471:
444:
154:
522:
413:
552:
538:
429:
386:
201:
461:
333:
177:
530:
480:
370:
421:
378:
80:
220:"Celebrated BC-CfE researcher Dr. Robert Hogg named to Order of Canada"
30:
494:
238:"Dr. Robert Hogg | Clinical Care and Management (CCM)"
118:
and a Fellow of the
Canadian Academy of Health Sciences.
86:
76:
61:
53:
45:
37:
25:
18:
200:General, Office of the Secretary to the Governor.
90:British Columbia Centre for Excellence in HIV/AIDS
334:"Hogg RS | BC Centre for Excellence in HIV/AIDS"
8:
178:BC Centre for Excellence in HIV/AIDS Profile
173:CTn CIHR Canadian HIV Trials Network Profile
109:Centre for Excellence in HIV/AIDS. He is a
15:
470:
460:
65:Order of Canada, Royal Society of Canada
189:
569:Fellows of the Royal Society of Canada
195:
193:
7:
292:"Robert S Hogg – Health Research BC"
224:BC Centre for Excellence in HIV/AIDS
14:
57:Improving the Care of HIV Persons
242:CIHR Canadian HIV Trials Network
149:Treatment as prevention strategy
168:Simon Fraser University Profile
564:Members of the Order of Canada
495:"CfE: Treatment as Prevention"
206:The Governor General of Canada
49:Australian National University
1:
523:10.1016/S0140-6736(06)69162-9
414:10.1016/S0140-6736(05)62505-6
462:10.1371/journal.pmed.0030356
590:
202:"Dr. Robert Stephen Hogg"
94:
69:
111:Simon Fraser University
371:10.1001/jama.280.6.547
133:Antiretroviral Therapy
574:HIV/AIDS researchers
278:scholar.google.com
98:
97:
71:Scientific career
581:
543:
542:
505:
499:
498:
491:
485:
484:
474:
464:
440:
434:
433:
397:
391:
390:
354:
348:
347:
345:
344:
330:
324:
323:
321:
320:
306:
300:
299:
288:
282:
281:
270:
264:
263:
252:
246:
245:
234:
228:
227:
226:. March 8, 2019.
216:
210:
209:
197:
107:
16:
589:
588:
584:
583:
582:
580:
579:
578:
549:
548:
547:
546:
517:(9534): 531–6.
507:
506:
502:
493:
492:
488:
442:
441:
437:
399:
398:
394:
356:
355:
351:
342:
340:
332:
331:
327:
318:
316:
308:
307:
303:
290:
289:
285:
272:
271:
267:
254:
253:
249:
236:
235:
231:
218:
217:
213:
199:
198:
191:
186:
164:
151:
143:
141:Drug resistance
135:
127:
116:Order of Canada
103:
46:Alma mater
33:
21:
12:
11:
5:
587:
585:
577:
576:
571:
566:
561:
551:
550:
545:
544:
500:
486:
435:
408:(9061): 1294.
392:
349:
325:
301:
283:
265:
247:
229:
211:
188:
187:
185:
182:
181:
180:
175:
170:
163:
162:External links
160:
155:Julio Montaner
150:
147:
142:
139:
134:
131:
126:
125:Access to Care
123:
101:Robert S. Hogg
96:
95:
92:
91:
88:
84:
83:
78:
74:
73:
67:
66:
63:
59:
58:
55:
54:Known for
51:
50:
47:
43:
42:
39:
35:
34:
29:
27:
23:
22:
20:Robert S. Hogg
19:
13:
10:
9:
6:
4:
3:
2:
586:
575:
572:
570:
567:
565:
562:
560:
559:Living people
557:
556:
554:
540:
536:
532:
528:
524:
520:
516:
512:
504:
501:
497:. 2012-01-25.
496:
490:
487:
482:
478:
473:
468:
463:
458:
454:
450:
449:PLOS Medicine
446:
439:
436:
431:
427:
423:
419:
415:
411:
407:
403:
396:
393:
388:
384:
380:
376:
372:
368:
364:
360:
353:
350:
339:
335:
329:
326:
315:
311:
310:"Robert Hogg"
305:
302:
297:
296:www.msfhr.org
293:
287:
284:
279:
275:
274:"Robert Hogg"
269:
266:
261:
257:
256:"Robert Hogg"
251:
248:
243:
239:
233:
230:
225:
221:
215:
212:
207:
203:
196:
194:
190:
183:
179:
176:
174:
171:
169:
166:
165:
161:
159:
156:
148:
146:
140:
138:
132:
130:
124:
122:
119:
117:
112:
106:
102:
93:
89:
85:
82:
79:
75:
72:
68:
64:
60:
56:
52:
48:
44:
40:
36:
32:
28:
24:
17:
514:
510:
503:
489:
452:
448:
438:
405:
401:
395:
365:(6): 547–9.
362:
358:
352:
341:. Retrieved
338:www.bccfe.ca
337:
328:
317:. Retrieved
313:
304:
295:
286:
277:
268:
259:
250:
241:
232:
223:
214:
205:
152:
144:
136:
128:
120:
100:
99:
87:Institutions
70:
455:(9): e356.
38:Nationality
553:Categories
343:2023-09-18
319:2023-09-18
314:www.sfu.ca
260:www.sfu.ca
184:References
539:11466139
531:16890841
481:16984218
430:26266152
387:34963438
81:HIV/AIDS
41:Canadian
472:1569883
422:9142067
379:9707146
537:
529:
511:Lancet
479:
469:
428:
420:
402:Lancet
385:
377:
153:Hogg,
77:Fields
62:Awards
31:Canada
535:S2CID
426:S2CID
383:S2CID
527:PMID
477:PMID
418:PMID
375:PMID
359:JAMA
26:Born
519:doi
515:368
467:PMC
457:doi
410:doi
406:349
367:doi
363:280
555::
533:.
525:.
513:.
475:.
465:.
451:.
447:.
424:.
416:.
404:.
381:.
373:.
361:.
336:.
312:.
294:.
276:.
258:.
240:.
222:.
204:.
192:^
105:CM
541:.
521::
483:.
459::
453:3
432:.
412::
389:.
369::
346:.
322:.
298:.
280:.
262:.
244:.
208:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.